Clinical Trials for Recurrent Primary Peritoneal Clear Cell Adenocarcinoma

Find clinical trials for recurrent primary peritoneal clear cell adenocarcinoma. Discover research opportunities and treatment options in your area.

2 Active Trials Found

Showing 2 trials on this page

Page 1 of 1

Vaccine Therapy Plus Pembrolizumab in Treating Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cavity Cancer

NCT ID: NCT05920798

This clinical trial is studying a new treatment approach for women with advanced ovarian, fallopian tube, or primary peritoneal cancer. Researchers want to see how well a combination of a special t...

Recruiting

Phase: PHASE1 Type: interventional Locations: Scottsdale, Arizona, United States, Jacksonville, Florida, United States +1 more

Pembrolizumab Combined With Bevacizumab With or Without Agonist Anti-CD40 CDX-1140 for the Treatment of Patients With Recurrent Ovarian Cancer

NCT ID: NCT05231122

This clinical trial is studying a new treatment approach for women with recurrent ovarian cancer, specifically looking at how well pembrolizumab and bevacizumab work together, with or without an ad...

Recruiting

Phase: PHASE2 Type: interventional Locations: Buffalo, New York, United States, Houston, Texas, United States

Related Conditions

Breast Cancer View clinical trials → Stroke View clinical trials → Obesity View clinical trials → Cancer View clinical trials → Healthy View clinical trials → Prostate Cancer View clinical trials →

Search All Trials Browse All Conditions